Has Hugh O'Flynn, MD received payments from drug or device companies?

Yes. Drug and device makers reported $12,245 in general payments to Hugh O'Flynn, MD across 50 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Hugh O'Flynn, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Hugh O'Flynn, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Hugh O'Flynn, MD

Orthopaedic Surgery · Peabody, MANPI 1437258738

Payments from drug & device makers

$12,245in general payments, 2019–2025

Across 50 payments — averaging $244.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Zimmer Biomet$12K
Pacira Therapeutics, Inc.$180
BD$130
Johnson & Johnson$76
Bioventus LLC$75
Smith+Nephew$73
plus $139 from 5 others

What the payments were for

Consulting fees$10,25084%
Travel & lodging$6145%
Food & beverage$1,38111%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Zimmer Biomet	26	$11,573
Pacira Therapeutics, Inc.	7	$180
BD	1	$130
Johnson & Johnson(2 entities)	3	$76
Bioventus LLC	2	$75
Smith+Nephew	4	$73
Aap Implants Inc	1	$36
Vertex	2	$34
Ferring Pharmaceuticals Inc.	2	$25
Abbott	1	$24
Avanos Medical	1	$21

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,245 in reported general payments places this provider in the 70th percentile of 542 orthopaedic surgery providers in Massachusetts.

See all orthopaedic surgery providers in Massachusetts →

Medicare billing

Part B allowed, 2024

$592,921

Medicare patients

830

Services billed

11,024

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Celecoxib	11	$198
Oxycodone Hcl	21	$115
Prednisone	21	$80
Meloxicam	24	$68

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Peabody

Paul TornettaBoston$16.7M
Thomas ThornhillBoston$12M
Stephen MurphyRoxbury Crossing$8M
Andrew FreibergBoston$5.9M
Jon WarnerBoston$5.5M
Wolfgang FitzBoston$3.7M
Young Min KwonBoston$2.8M
Brian KwonWaltham$1.9M
Simon ChaoNorth Easton$1.6M
Scott SigmanNorth Chelmsford$1.4M

See the full list for Massachusetts →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →